AbstractBackgroundKidney transplantation (KT) is the treatment of choice for end-stage renal disease patients. The spouse is a major donor in living KT. Clinical outcomes of spousal donor KT are not inferior to those of living related donor KT. In this study, we compared clinical outcomes between ABO-compatible (ABOc) and ABO-incompatible (ABOi) spousal donor KTs.MethodsThirty-two cases of spousal donor KT performed from January 2011 to August 2013 were analyzed retrospectively. Twenty-one ABOc KTs and 11 ABOi KTs were performed. We investigated patient survival, graft survival, acute rejection, graft function, and complications.ResultsDuring follow-up, patient and graft survival rates were 100% in both groups. There were no significant dif...
BACKGROUND: Kidney transplant candidates are blood group incompatible with roughly one out of three ...
This study aimed to compare the outcomes of ABO-incompatible kidney transplantation (ABOiKT) with AB...
Donor-recipient ABO and/or HLA incompatibility used to lead to donor decline. Development of alterna...
Background: Kidney transplantation (KT) is the treatment of choice for end-stage renal disease patie...
AbstractBackgroundKidney transplantation (KT) is the treatment of choice for end-stage renal disease...
BACKGROUND:ABO incompatible kidney transplantation (ABOi-KT) is an important approach for overcoming...
ABO incompatible kidney transplantation (ABOi-KT) is an important approach for overcoming donor shor...
Background Kidney transplantation is the most preferred type of renal displacement therapy for end s...
PubMed ID: 22841250Objective: To compare the outcomes of spousal and living unrelated donor (LUD) al...
Background. In countries without a national organization for retrieval and distribution of organs o...
PubMedID: 24821146The worldwide shortage of organs available for transplantation has led to the use ...
Introduction: ABO-incompatible kidney transplantation (ABOiKTx) expands the living donor pool. There...
<p>(A) Overall incidence of BPAR. (B) BPAR-free survival rate. (C) Incidence of BPAR after the prope...
AIMS: ABO-incompatible (ABOi) kidney transplantation (KT) is being increasingly performed to overcom...
IntroductionLiving donor kidney transplantation is preferable to deceased donor transplantation due ...
BACKGROUND: Kidney transplant candidates are blood group incompatible with roughly one out of three ...
This study aimed to compare the outcomes of ABO-incompatible kidney transplantation (ABOiKT) with AB...
Donor-recipient ABO and/or HLA incompatibility used to lead to donor decline. Development of alterna...
Background: Kidney transplantation (KT) is the treatment of choice for end-stage renal disease patie...
AbstractBackgroundKidney transplantation (KT) is the treatment of choice for end-stage renal disease...
BACKGROUND:ABO incompatible kidney transplantation (ABOi-KT) is an important approach for overcoming...
ABO incompatible kidney transplantation (ABOi-KT) is an important approach for overcoming donor shor...
Background Kidney transplantation is the most preferred type of renal displacement therapy for end s...
PubMed ID: 22841250Objective: To compare the outcomes of spousal and living unrelated donor (LUD) al...
Background. In countries without a national organization for retrieval and distribution of organs o...
PubMedID: 24821146The worldwide shortage of organs available for transplantation has led to the use ...
Introduction: ABO-incompatible kidney transplantation (ABOiKTx) expands the living donor pool. There...
<p>(A) Overall incidence of BPAR. (B) BPAR-free survival rate. (C) Incidence of BPAR after the prope...
AIMS: ABO-incompatible (ABOi) kidney transplantation (KT) is being increasingly performed to overcom...
IntroductionLiving donor kidney transplantation is preferable to deceased donor transplantation due ...
BACKGROUND: Kidney transplant candidates are blood group incompatible with roughly one out of three ...
This study aimed to compare the outcomes of ABO-incompatible kidney transplantation (ABOiKT) with AB...
Donor-recipient ABO and/or HLA incompatibility used to lead to donor decline. Development of alterna...